12:00 AM
 | 
Aug 14, 2000
 |  BC Week In Review  |  Company News  |  Deals

Abgenix, SangStat deal

SANG acquired an exclusive worldwide license to market and sell ABX-CBL, a mouse monoclonal antibody against CBL antigen ( CD147) developed by ABGX, and the right...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >